Related Experiment Video
Updated: Jan 3, 2026

In Vivo Functional Study of Disease-associated Rare Human Variants Using Drosophila
Published on: August 20, 2019
RegSNPs-intron: a computational framework for predicting pathogenic impact of intronic single nucleotide variants
Hai Lin1,2, Katherine A Hargreaves3, Rudong Li1,2
1Center for Computational Biology and Bioinformatics, Indiana University School of Medicine, Indianapolis, IN, 46202, USA.
We developed RegSNPs-intron, a novel algorithm to predict disease-causing potential of intronic single nucleotide variants (iSNVs). This tool, validated with ASSET-seq, aids in prioritizing iSNVs for genetic disease research.
Area of Science:
- Genomics
- Bioinformatics
- Molecular Biology
Background:
- Intronic single nucleotide variants (SNVs) are understudied for their disease-causing potential.
- Systematic investigation of intronic SNVs (iSNVs) is crucial for understanding genetic disorders.
- Existing methods lack comprehensive evaluation of iSNVs' impact on molecular mechanisms.
Purpose of the Study:
- To develop and validate a computational tool for predicting the pathogenicity of iSNVs.
- To integrate diverse biological features for accurate iSNV impact assessment.
- To establish a high-throughput experimental method for validating iSNV effects on RNA splicing.
Main Methods:
- Development of the RegSNPs-intron algorithm using a random forest classifier.
- Integration of RNA splicing, protein structure, and evolutionary conservation features.
- Validation using a high-throughput functional reporter assay, ASSET-seq (ASsay for Splicing using ExonTrap and sequencing).
Main Results:
- RegSNPs-intron demonstrated excellent performance in evaluating pathogenic impacts of iSNVs.
- ASSET-seq successfully assessed the functional consequences of iSNV predictions on splicing.
- The combined approach effectively prioritizes iSNVs for disease pathogenesis studies.
Conclusions:
- RegSNPs-intron provides a robust method for assessing iSNV pathogenicity.
- ASSET-seq offers a scalable platform for functional validation of splicing alterations.
- The integrated strategy enhances the identification of disease-associated intronic variants.
More Related Videos
09:34Targeted Next-generation Sequencing and Bioinformatics Pipeline to Evaluate Genetic Determinants of Constitutional Disease
Published on: April 4, 2018
08:46Implementation of In Vitro Drug Resistance Assays: Maximizing the Potential for Uncovering Clinically Relevant Resistance Mechanisms
Published on: December 9, 2015
Related Concept Videos
Comparing Copy Number Variations and SNPs
Copy number variations or CNVs are the structural variations that cover more than 1kb of DNA sequence. The single nucleotide polymorphism (SNP), on the other hand, is a single nucleotide change or a point mutation that is found in more than 1%...
Single Nucleotide Polymorphisms-SNPs
Point and Frameshift Mutations